Bank Pictet & Cie (Europe)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.71M | Buy |
320,378
+17,176
| +6% | +$449K | 0.15% | 80 |
|
|
2026
Q1 | $8.51M | Buy |
+303,202
| New | +$8.07M | 0.18% | 79 |
|
|
2025
Q1 | – | Sell |
-10,100
| Closed | -$268K | – | 202 |
|
|
2024
Q4 | $268K | Hold |
10,100
| – | – | 0.01% | 152 |
|
|
2024
Q3 | $292K | Hold |
10,100
| – | – | 0.01% | 136 |
|
|
2024
Q2 | $283K | Sell |
10,100
-13,100
| -56% | -$361K | 0.01% | 140 |
|
|
2024
Q1 | $644K | Buy |
23,200
+2,000
| +9% | +$55.5K | 0.02% | 121 |
|
|
2023
Q4 | $610K | Sell |
21,200
-4,024
| -16% | -$122K | 0.02% | 167 |
|
|
2023
Q3 | $837K | Sell |
25,224
-28,350
| -53% | -$1M | 0.03% | 146 |
|
|
2023
Q2 | $1.97M | Sell |
53,574
-2,245
| -4% | -$87.4K | 0.07% | 108 |
|
|
2023
Q1 | $2.28M | Sell |
55,819
-11,318
| -17% | -$489K | 0.09% | 86 |
|
|
2022
Q4 | $3.44M | Sell |
67,137
-2,724
| -4% | -$131K | 0.17% | 74 |
|
|
2022
Q3 | $3.06M | Buy |
69,861
+6,600
| +10% | +$321K | 0.15% | 76 |
|
|
2022
Q2 | $3.32M | Buy |
63,261
+8,040
| +15% | +$410K | 0.15% | 70 |
|
|
2022
Q1 | $2.86M | Buy |
55,221
+7,854
| +17% | +$408K | 0.11% | 79 |
|
|
2021
Q4 | $2.8M | Hold |
47,367
| – | – | 0.1% | 82 |
|
|
2021
Q3 | $2.04M | Buy |
47,367
+28,076
| +146% | +$1.24M | 0.08% | 89 |
|
|
2021
Q2 | $755K | Buy |
19,291
+212
| +1% | +$8.24K | 0.03% | 114 |
|
|
2021
Q1 | $691K | Sell |
19,079
-21,383
| -53% | -$759K | 0.03% | 112 |
|
|
2020
Q4 | $1.49M | Buy |
40,462
+12,538
| +45% | +$460K | 0.07% | 84 |
|
|
2020
Q3 | $972K | Sell |
27,924
-3,731
| -12% | -$131K | 0.05% | 82 |
|
|
2020
Q2 | $982K | Sell |
31,655
-7,439
| -19% | -$253K | 0.07% | 74 |
|
|
2020
Q1 | $1.21M | Buy |
39,094
+4,882
| +14% | +$166K | 0.11% | 70 |
|
|
2019
Q4 | $1.27M | Buy |
34,212
+626
| +2% | +$22.3K | 0.19% | 71 |
|
|
2019
Q3 | $1.15M | Buy |
33,586
+3,268
| +11% | +$119K | 0.2% | 63 |
|
|
2019
Q2 | $1.25M | Sell |
30,318
-4,314
| -12% | -$171K | 0.21% | 66 |
|
|
2019
Q1 | $1.4M | Buy |
34,632
+2,727
| +9% | +$109K | 0.24% | 64 |
|
|
2018
Q4 | $1.32M | Sell |
31,905
-5,913
| -16% | -$245K | 0.27% | 59 |
|
|
2018
Q3 | $1.58M | Sell |
37,818
-919
| -2% | -$35.4K | 0.22% | 67 |
|
|
2018
Q2 | $1.33M | Sell |
38,737
-10,287
| -21% | -$352K | 0.21% | 68 |
|
|
2018
Q1 | $1.65M | Buy |
49,024
+13,409
| +38% | +$461K | 0.27% | 62 |
|
|
2017
Q4 | $1.22M | Buy |
35,615
+9,065
| +34% | +$309K | 0.17% | 71 |
|
|
2017
Q3 | $899K | Buy |
26,550
+8,938
| +51% | +$287K | 0.13% | 114 |
|
|
2017
Q2 | $561K | Buy |
17,612
+9,275
| +111% | +$292K | 0.08% | 138 |
|
|
2017
Q1 | $271K | Buy |
+8,337
| New | +$263K | 0.04% | 171 |
|
Other funds holding PFE
Bank Pictet & Cie (Europe)'s PFE Position: Q2 2026 in Review
Bank Pictet & Cie (Europe) increased its Pfizer (PFE) stake by 5.7% in Q2 2026, buying an estimated $449K and bringing the position to 320,378 shares worth $7.71M. The position accounts for 0.15% of the portfolio, ranked #80.
Bank Pictet & Cie (Europe) first reported a position in PFE in Q1 2017 and has held it in 34 quarters since. The position peaked at $8.51M in Q1 2026. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bank Pictet & Cie (Europe) held 320,378 shares of Pfizer worth $7.71M as of Q2 2026.
- Bank Pictet & Cie (Europe) bought 17,176 Pfizer shares in Q2 2026, an estimated $449K.
- Pfizer made up 0.15% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #80 holding.
- Bank Pictet & Cie (Europe) first reported a position in Pfizer in Q1 2017 and has held it in 34 quarters since.
- Bank Pictet & Cie (Europe)'s Pfizer position peaked at $8.51M in Q1 2026.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.